Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Glioblastoma 80 Prostatic Neoplasms 57 Carcinoma, Non-Small-Cell Lung 54 Breast Neoplasms 54 Esophageal Neoplasms 48 Rectal Neoplasms 42 Lung Neoplasms 42 Brain Neoplasms 34 Squamous Cell Carcinoma of Head and Neck 33 Head and Neck Neoplasms 33 Gliosarcoma 31 Pancreatic Neoplasms 29 Uterine Cervical Neoplasms 28 Neoplasms 25 Glioma 24 Neoplasm Metastasis 23 Sarcoma 22 Oropharyngeal Neoplasms 21 Esophageal Squamous Cell Carcinoma 20 Melanoma 19 Astrocytoma 18 Adenocarcinoma Of Esophagus 15 Stomach Neoplasms 14 Precursor Cell Lymphoblastic Leukemia-Lymphoma 12 Carcinoma, Squamous Cell 12 Urinary Bladder Neoplasms 11 Mouth Neoplasms 11 Lymphoma, Follicular 11 Central Nervous System Neoplasms 11 Carcinoma 11

Interventions

Nivolumab 6 Imatinib Mesylate 4 Ipilimumab 3 Cetuximab 3 pembrolizumab 2 palbociclib 2 Specimen Handling 2 Radiotherapy 2 Radiosurgery 2 Protons 2 Proton Therapy 2 Pemetrexed 2 Magnetic Resonance Spectroscopy 2 Cyclophosphamide 2 tazemetostat 1 spartalizumab 1 relatlimab 1 nilotinib 1 camrelizumab 1 avelumab 1 atezolizumab 1 apatinib 1 Zoledronic Acid 1 X-Rays 1 Tiragolumab 1 Thiotepa 1 Surveys and Questionnaires 1 Radiotherapy, Intensity-Modulated 1 Radiation 1 Photochemotherapy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Chordoma × Radiation × Clear all

NCT03595228 2023-04-14

BN Brachyury and Radiation in Chordoma

Bavarian Nordic

Phase 2 Completed

29 enrolled 20 charts

Chordoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡